Dr. Gleave to give MSFHR-VCHRI lecture on the PC-TRiADD Model

Date Posted: 
2014-01-09

The Michael Smith Foundation for Health Research (MSFHR) and the Vancouver Coastal Research Institute are pleased to present a lecture by one of British Columbia’s most innovative scientists — a man who has bridged the gap between clinical research and new commercial treatments for disease.

Dr. Martin Gleave is the most recent recipient of the MSFHR Aubrey J. Tingle Prize, given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research — as well as its uptake — to improve health and the health system in BC and globally.

Please join Dr. Diane Finegood, MSFHR president and CEO, as she presents Dr. Gleave with his award. Dr. Gleave will also deliver a lecture and take questions from the audience.

Title:  Bridging the Mind to Market Gap in Translational Cancer Research: The Vancouver PC-TRiADD Model

Presenter:  Dr. Martin Gleave MD, FRCSC, FACS

Date:  Tuesday, January 14, 2014

Time:  4 – 5 p.m. (presentation and lecture); 5 – 6 p.m. (reception)

Location: Paetzold Auditorium & Atrium, 1st Floor, Jim Pattison Pavilion, Vancouver General Hospital, 855 West 12th Avenue

Dr. Martin Gleave is executive director of the Vancouver Prostate Centre, chief executive officer of PC-TRIADD, and a distinguished professor in the department of urologic sciences at UBC. His major research focus involves the study of cellular and molecular mechanisms mediating progression of prostate cancer to its lethal stage of androgen independence, and use of this information to develop integrated multimodality therapies that specifically target these mechanisms. He is the scientific founder of OncoGenex Pharmaceuticals Inc.

The Michael Smith Foundation for Health Research harnesses the power of health research to improve the health of British Columbians and their health system. It does this by building BC’s capacity for world-class research by funding the best scientists; coordinating the sharing of health research resources across the province; and bringing people together for health research planning and action. Learn more at www.msfhr.org.

Vancouver Coastal Health Research Institute (VCHRI) is the research body of Vancouver Coastal Health. VCHRI includes three of BC’s largest academic and teaching health sciences centres — Vancouver General Hospital, UBC Hospital, and GF Strong Rehabilitation Centre — as well as many other hospitals and public health agencies across Vancouver Coastal Health. VCHRI is academically affiliated with the UBC Faculty of Medicine and is one of Canada’s top funded research centres receiving between $80 and $100 million in research funding annually.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Terry Fox

Terry Fox Run - September 15, 2019

This year's Terry Fox Run takes place on Sunday September 15, in locations across Canada.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Monday, September 16, 2019

Drs Cox, Gleave and Goldenberg awarded Prostate Cancer Canada and Movember 2019 Discovery Grants

Drs Cox, Gleave and Goldenberg
Thursday, September 12, 2019

Drs. Wyatt and Sorensen receive 2019 UBC Faculty of Medicine Awards for Distinguished Achievement

Drs Wyatt and Sorensen
Tuesday, September 10, 2019

Drs. Sorensen, Ester and Huntsman elected to Royal Society of Canada

Drs Sorensen, Ester, Huntsman